James D. Gotz
OVERVIEW
James Gotz is co-chair of Hausfeld’s Public Entity and Environmental & Product Liability Practice Groups. For more than 30 years, whether in his role as first-chair trial lawyer, client counselor or litigation manager, James has represented public entities and individual claimants throughout the country seeking justice through high-impact litigation.
James co-leads the firm’s deep-bench of attorneys representing public entities in environmental, consumer and affirmative firearm litigation. Examples include:
- The first-in-the-nation case seeking to hold chemical manufacturers responsible for contamination of one of the largest drinking water authority’s wells from decades-long release of 1,4-dioxane into groundwater, as well as the first state-wide case against those same companies;
- Lawsuits on behalf of state Attorneys General to hold the oil industry accountable for their role in suppressing renewable energy technologies in violation of antitrust laws, and deceiving the public about the companies’ causative role in climate change; and
- Lawsuits on behalf of cities and states to hold the firearm industry accountable for deceptive marketing, the proliferation of unlawful ghost guns and the industry’s failure to implement reasonable controls to reduce preventable gun violence.
James also contributes his complex litigation experience and best practice strategies to the firm’s human rights cases. As an example, James counsels the Hausfeld team representing the largest class of victims in US human rights litigation history, to hold French bank BNP Paribas accountable for financially aiding and abetting the genocidal atrocities inflicted by the Government of South Sudan upon its citizens.
Earlier in his career, James was judicially appointed or invited to assume leadership roles in multiple drug and device MDLs, bringing his experience and skills to matters such as legal challenges to the admissibility of expert opinions (so-called Daubert challenges), litigation strategy and management as well as global resolution on behalf of tens of thousands of personal injury claimants. In addition, he has contributed to thought leadership on MDL-related issues through Emory Law School’s Institute for Complex Litigation and Mass Claims and advocated at hearings before the federal Advisory Committee on Evidence Rules concerning proposed changes to Rule 702 of the Federal Rules of Evidence.
In every case, James brings his considered and empathic approach to secure the greatest possible success for his clients while also preserving civility throughout the adversarial process.
EDUCATION
Suffolk University Law School, J.D., with honors, 1994
University of Michigan, B.A., 1991
BAR ADMISSIONS
Massachusetts
United States District Court for the District of Massachusetts
United States District Court for the Western District of Michigan
AFFILIATIONS
American Association for Justice - Section on Toxic, Environment and Pharmaceutical Torts, Past Chair
American Bar Foundation, Fellow (Invited 2025)
Boston Bar Association - Tort Committee, Former Co-Chair
Harvard Law School’s Trial Advocacy Workshop, Faculty Member (2009-2011, 2014-2015)
Massachusetts Academy of Trial Attorneys - Board of Governors, Former Member
Massachusetts Bar Association - Civil Litigation Section Council, Former Member
WHAT OTHERS SAY
Lawdragon
- The Green 500: Leaders in Environmental Law in 2024
- 500 Leading Plaintiff Consumer Lawyers since 2019
- 500 Leading Litigators in America in 2022
Other
- Invited to participate as a faculty member for Harvard Law School’s Annual Trial Advocacy Workshop from 2009-2011 and 2014-2015, in recognition of his skills as a trial lawyer.
- Frequently invited as a thought leader to speak about current issues in mass torts and drug/device MDLs at academic forums including the Duke Law School’s Bolch Judicial Institute and Emory Law School’s Institute for Complex Litigation and Mass Claims.
NEWS
EVENTS
"The State of Daubert Law and Strategies for Overcoming Expert Challenges," American Association for Justice Annual Convention, Section on Toxic, Environmental and Pharmaceutical Litigation (July 2020), Speaker